Intelligence / Healthtech / PMA Approvals / Contego Medical, INC.
Contego Medical, INC.
4 Nov 2026: Device change approved (PMA) · Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection. Recorded in the openFDA device PMA data.
- Decided
- 4 Nov 2026
- Device
- Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection
- Specialty
- Cardiovascular
- Type
- Supplement (Panel Track)
- Reason
- Change Design/Components/Specifications/Material
- Reference
- P240009 S006
- Location
- Raleigh, NC
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Find the decision makers at Contego Medical, INC.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Contego Medical, INC. in our registers.
More in Cardiovascular
PMA Approvals
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.